Circulating Tumor DNA–Defined Minimal Residual Disease in Solid Tumors: Opportunities to Accelerate the Development of Adjuvant Therapies-Reference-Cited by-同舟云学术

Circulating Tumor DNA–Defined Minimal Residual Disease in Solid Tumors: Opportunities to Accelerate the Development of Adjuvant Therapies

Published:2018-12-10 Issue:35 Volume:36 Page:3437-3440
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Dasari Arvind¹,Grothey Axel¹,Kopetz Scott¹

Affiliation:

1. Arvind Dasari, The University of Texas MD Anderson Cancer Center, Houston, TX; Axel Grothey, The University of Tennessee West Cancer Center, Memphis, TN; and Scott Kopetz, The University of Texas MD Anderson Cancer Center, Houston, TX

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2018.78.9032

Reference38 articles.

1. Cancer statistics, 2017

2. Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival

3. Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology

4. Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology

5. NCCN Guidelines Insights: Breast Cancer, Version 1.2017

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-Cancer Early Detection: The New Frontier in Cancer Early Detection;Annual Review of Medicine;2024-01-29

2. Hypermethylated SHOX2 in circulating cell-free DNA post renal cell carcinoma surgery as TNM-independent biomarker for recurrence risk;American Journal of Translational Research;2024

3. Circulating tumor DNA analysis predicts recurrence and avoids unnecessary adjuvant chemotherapy in I–IV colorectal cancer;Therapeutic Advances in Medical Oncology;2024-01

4. Patient-derived tumor organoids from resected non-small cell lung cancers for high-throughput response testing with approved and repurposed drugs;2023-10-21

5. Detection of Glioma-Related Hotspot Mutations Through Sequencing of Cerebrospinal Fluid (CSF)-Derived Circulating Tumor DNA: A Pilot Study on CSF-Based Liquid Biopsy for Primary Spinal Cord Astrocytoma;Neurospine;2023-06-30